SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-256208
Filing Date
2022-10-03
Accepted
2022-10-03 08:31:43
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d324236ds3.htm S-3 300923
2 EX-4.4 d324236dex44.htm EX-4.4 34603
3 EX-4.5 d324236dex45.htm EX-4.5 253502
4 EX-5.1 d324236dex51.htm EX-5.1 32636
5 EX-23.1 d324236dex231.htm EX-23.1 2487
6 EX-FILING FEES d324236dexfilingfees.htm EX-FILING FEES 33671
7 GRAPHIC g324236g03p01.jpg GRAPHIC 42121
8 GRAPHIC g324236g32p10.jpg GRAPHIC 45264
9 GRAPHIC g324236g77p19.jpg GRAPHIC 7570
  Complete submission text file 0001193125-22-256208.txt   775787
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267702 | Film No.: 221286087
SIC: 2834 Pharmaceutical Preparations